VCYT FY 2015 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M+29.6% YoY

Gross Profit

$28M56.6% margin

Operating Income

-$33M-67.6% margin

Net Income

-$34M-68.1% margin

EPS (Diluted)

$-1.30

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$33M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$75M

Total Liabilities

$24M

Stockholders' Equity

$51M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$38M	+29.6%
Gross Profit	$28M	$22M	+29.8%
Operating Income	-$33M	-$29M	-15.4%
Net Income	-$34M	-$29M	-14.7%